Trial · NCT03922321
Results by group29
Each measurement the trial posted, group by group, in the words and numbers it posted.
21 to 29 of 29
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Serum Concentration at the End of the Dosing Interval (Ctrough) of RVT-1401 | RVT-1401 | Week 2 | 4.018 | Standard Deviation 5.9584 | mg/L |
| Serum Concentration at the End of the Dosing Interval (Ctrough) of RVT-1401 | RVT-1401 | Week 3 | 12.075 | Standard Deviation 14.6431 | mg/L |
| Serum Concentration at the End of the Dosing Interval (Ctrough) of RVT-1401 | RVT-1401 | Week 4 | 1.284 | Standard Deviation 2.3063 | mg/L |
| Serum Concentration at the End of the Dosing Interval (Ctrough) of RVT-1401 | RVT-1401 | Week 5 | 0.167 | Standard Deviation 0.1682 | mg/L |
| Serum Concentration at the End of the Dosing Interval (Ctrough) of RVT-1401 | RVT-1401 | Week 6 Day 36 | 0.660 | Standard Deviation 1.5529 | mg/L |
| Serum Concentration at the End of the Dosing Interval (Ctrough) of RVT-1401 | RVT-1401 | Week 7 | 0.077 | Standard Deviation 0.0381 | mg/L |
| Number of Participants With Anti-RVT-1401 Antibody and Confirmed Anti-RVT-1401 Antibody at Week 7 | RVT-1401 | Initial analysis: negative anti-RVT-1401 antibody | 5 | Participants | |
| Number of Participants With Anti-RVT-1401 Antibody and Confirmed Anti-RVT-1401 Antibody at Week 7 | RVT-1401 | Initial analysis: potentially positive anti-RVT-1401 antibody | 2 | Participants | |
| Number of Participants With Anti-RVT-1401 Antibody and Confirmed Anti-RVT-1401 Antibody at Week 7 | RVT-1401 | Confirmed analysis: negative anti-RVT-1401 antibody | 2 | Participants |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03922321/results?page=2